FDA Approves Fayuvi, the First Gene Therapy for Children with Sanfilippo Syndrome Type A
One-time treatment provides a new option for pediatric patients with a rare, progressive genetic disorder As announced in a recent press release, the U.S. Food and Drug Administration has approved…